TARS SG&A Expenses

Tarsus Pharmaceuticals Inc · SG&A Expenses

TARS logo

TARS SG&A Expenses

Latest reported$526.44M
TARS SG&A Expenses ($448.00K → $526.44M)
High-resolution chart · PNG

TARS sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tarsus Pharmaceuticals Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
427,323,000
237,310,000
108,700,000
44,949,000
25,397,000
7,926,000
1,062,000
448,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.